Nova Eye Medical

Nova Eye Medical is a specialized ophthalmology device manufacturer focused on glaucoma treatment solutions. The company develops and markets three primary product lines for surgical glaucoma management: iTrack™ Advance (an illuminated microcatheter for canaloplasty and goniotomy), iTrack™ (the original microcatheter platform used in over 150,000 procedures since 2008), and Molteno 3 (a glaucoma drainage implant for severe and complex cases). The iTrack™ Advance holds FDA 510(k) clearance (#K221872) and CE Mark 2862 for treatment of open-angle glaucoma in adult patients via catheterization and viscodilation of Schlemm's canal. The company also offers Shear Clear™ Technology, a shear-thinning viscoelastic innovation designed to improve fluid dynamics during canaloplasty procedures. Nova Eye operates as a publicly listed company (ASX) with a focus on surgeon partnerships and clinical evidence generation. Products are manufactured to support both interventional canaloplasty techniques and traditional drainage device implantation, positioning the company across the full spectrum of glaucoma surgical care from early-stage outflow restoration to advanced implant-based therapy.